The FDA-approved tool works by reprioritizing CTPA exams to the top of a radiologist’s work list when the scan is positive for PE.

Such behaviors may lead to delays in cancer diagnosis and treatment and adverse outcomes, experts wrote Tuesday in Radiology. 

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

“Responsibility equals accountability equals ownership. And a sense of ownership is the most powerful weapon a team or organization can have.”

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.

“These findings should be considered when designing workflow-related and other interventions seeking to reduce errors," experts wrote in AJR. 

An inordinate number of patients with metallic hardware were receiving inappropriate MRIs without a key sequence to reduce related artifacts. 

The findings should serve as a call to action for radiologists to increase awareness about LDCT, experts contended.